dr donna h ryan glp 1 Video: GLP-1 Medications Revolutionize Obesity and Diabetes Care, With Exciting Advances on Horizon Donna H. Ryan, MD |

Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, et al

doi: 10.1016/j.envint.2017.12.035 108 BurkRFNorsworthyBKHillKEMotleyAKByrneDW

However, people taking Zepbound are still experiencing a range of negative side effects and are pursuing legal action against Eli Lilly

Precision Health Assessment When appetite drops, nutrition matters even more

Metrics to track Beyond weight, track these metrics weekly or biweekly: Waist circumference at the navel, first thing in the morning Hip circumference at the widest point Energy level on a 1 to 10 scale Sleep quality on a 1 to 10 scale Appetite level on a 1 to 10 scale Side effects type and severity Exercise type and duration Request blood work from your provider at baseline, 12 weeks, and 24 weeks at minimum